STAAR Surgical Co (STAA) Free cash flow 2016–2025
STAAR Surgical Co (STAA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$40.0MFY2025 · since FY2016: -$2.2M → -$40.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$40.0M | -422.2% |
| FY2024 | -$7.7M | -113.4% |
| FY2023 | -$3.6M | -120.4% |
| FY2022 | $17.6M | -41.9% |
| FY2021 | $30.3M | +141.6% |
| FY2020 | $12.5M | -20.1% |
| FY2019 | $15.7M | +49.2% |
| FY2018 | $10.5M | +482.3% |
| FY2017 | $1.8M | +183.8% |
| FY2016 | -$2.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More STAA financial trends
STAA RevenueSTAA Net incomeSTAA Net marginSTAA Gross profitSTAA Gross marginSTAA Operating incomeSTAA Operating marginSTAA Operating cash flowSTAA Capital expendituresSTAA Return on equitySTAA Stock buybacksSTAA Dividends paidSTAA Total assetsSTAA Total liabilitiesSTAA Shareholders’ equitySTAA overview →